罕见疾病临床研究网络 (RDCRN) 的数据共享经验,指导和资源
Elaine Schwendeman1, Henry J Kaminski2, Adeline Vanderver3,4
1Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Clinical and translational science
|September 3, 2025
概括
罕见疾病临床研究网络制定了分享罕见疾病数据的指南,确保参与者的权利和数据完整性. 这促进了合作研究,促进了临床和转化科学.
科学领域:
- 临床和翻译科学
- 罕见疾病研究
- 数据科学
背景情况:
- 罕见疾病临床研究网络 (RDCRN) 旨在通过数据共享推进罕见疾病研究.
- 审查了联盟内部现有的数据共享实践和已发表的文献.
- 制定了指导文件以标准化数据管理和共享协议.
研究的目的:
- 在罕见疾病研究联盟中建立成功的数据共享的共同要素.
- 制定知情同意,合同语言和管理数据共享和使用的联盟政策的原则.
- 确保在保护参与者的权利的同时遵守适当的数据使用限制.
主要方法:
- 在已建立的RDCRN联盟中审查数据共享实践.
- 对罕见疾病数据共享的出版文献进行分析.
- 制定指导文件:"RDCRN关于为个人联盟建立数据共享和数据管理指导的建议"和"数据共享检查清单的原则".
主要成果:
- 关键原则强调知情同意,允许数据共享,同时保护参与者的权利.
- 研究数据库必须跟踪参与者的数据使用和共享偏好.
- 联盟协议应指定一个行政核心 (Admin Core) 作为主要的数据管理员,以进一步分享NIH政策.
结论:
- 在罕见疾病研究中,RDCRN指导促进安全和道德的数据共享实践.
- 标准化数据共享政策增强了合作研究,加速了科学发现.
- 这些经验可以为其他研究网络的数据共享策略提供信息.
相关概念视频
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Hazard Ratio
241
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
241
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Relative Risk
340
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
340
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Data Collection I
6.6K
Data collection gathers information needed to make accurate judgments about a patient's present condition. During a health history interview, subjective data is collected from the patient, their caregivers, or family members, and objective data is collected through observations and physical assessment. Patients are the primary source of subjective data. Thus information gathered from patients through interviews, observations, and physical examination is primary data. Secondary sources of...
6.6K


